Literature DB >> 30923185

Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysis.

Eleni Sofianopoulou1,2, Stephen Kaptoge1, Stefan Gräf3,4,5, Charaka Hadinnapola3, Carmen M Treacy3,6, Colin Church7,8, Gerry Coghlan9, J Simon R Gibbs10,11, Matthias Haimel3,4,5, Luke S Howard10,11, Martin Johnson7, David G Kiely12, Allan Lawrie13, James Lordan14, Robert V MacKenzie Ross15, Jennifer M Martin3,4,5, Shahin Moledina16, Michael Newnham3, Andrew J Peacock7, Laura C Price10,17, Christopher J Rhodes18, Jay Suntharalingam15, Emilia M Swietlik3,6, Mark R Toshner3,6, John Wharton18, Martin R Wilkins18, Stephen J Wort10,17, Joanna Pepke-Zaba6, Robin Condliffe12, Paul A Corris14, Emanuele Di Angelantonio1,19,20, Steeve Provencher21, Nicholas W Morrell3,5,2.   

Abstract

While traffic and air pollution exposure is associated with increased mortality in numerous diseases, its association with disease severity and outcomes in pulmonary arterial hypertension (PAH) remains unknown.Exposure to particulate matter with a 50% cut-off aerodynamic diameter ≤2.5 μm (PM2.5), nitrogen dioxide (NO2) and indirect measures of traffic-related air pollution (distance to main road and length of roads within buffer zones surrounding residential addresses) were estimated for 301 patients with idiopathic/heritable PAH recruited in the UK National Cohort Study of Idiopathic and Heritable PAH. Associations with transplant-free survival and pulmonary haemodynamic severity at baseline were assessed, adjusting for confounding variables defined a prioriHigher estimated exposure to PM2.5 was associated with higher risk of death or lung transplant (unadjusted hazard ratio (HR) 2.68 (95% CI 1.11-6.47) per 3 μg·m-3; p=0.028). This association remained similar when adjusted for potential confounding variables (HR 4.38 (95% CI 1.44-13.36) per 3 μg·m-3; p=0.009). No associations were found between NO2 exposure or other traffic pollution indicators and transplant-free survival. Conversely, indirect measures of exposure to traffic-related air pollution within the 500-1000 m buffer zones correlated with the European Society of Cardiology/European Respiratory Society risk categories as well as pulmonary haemodynamics at baseline. This association was strongest for pulmonary vascular resistance.In idiopathic/heritable PAH, indirect measures of exposure to traffic-related air pollution were associated with disease severity at baseline, whereas higher PM2.5 exposure may independently predict shorter transplant-free survival.
Copyright ©ERS 2019.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30923185     DOI: 10.1183/13993003.01429-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Differentially expressed circular RNAs in air pollution-exposed rat embryos.

Authors:  Zheng Li; Jianqing Ma; Jianxiong Shen; Matthew T V Chan; William K K Wu; Zhanyong Wu
Journal:  Environ Sci Pollut Res Int       Date:  2019-10-21       Impact factor: 4.223

Review 2.  'There and Back Again'-Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension.

Authors:  Emilia M Swietlik; Matina Prapa; Jennifer M Martin; Divya Pandya; Kathryn Auckland; Nicholas W Morrell; Stefan Gräf
Journal:  Genes (Basel)       Date:  2020-11-26       Impact factor: 4.096

Review 3.  Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Krittika Teerapuncharoen; Remzi Bag
Journal:  Lung       Date:  2022-05-29       Impact factor: 2.584

4.  Ambient Air Pollution and Adverse Waitlist Events Among Lung Transplant Candidates.

Authors:  Andrew M Hallett; Yijing Feng; Miranda R Jones; Errol L Bush; Christian A Merlo; Dorry L Segev; Mara McAdams-DeMarco
Journal:  Transplantation       Date:  2021-05-25       Impact factor: 5.385

Review 5.  Genomics of Particulate Matter Exposure Associated Cardiopulmonary Disease: A Narrative Review.

Authors:  Julia Citron; Emma Willcocks; George Crowley; Sophia Kwon; Anna Nolan
Journal:  Int J Environ Res Public Health       Date:  2019-11-07       Impact factor: 3.390

6.  Ambient air pollution exposure and radiographic pulmonary vascular volumes.

Authors:  Andrew J Synn; Katerina L Byanova; Wenyuan Li; Diane R Gold; Qian Di; Itai Kloog; Joel Schwartz; Raúl San José Estépar; George R Washko; George T O'Connor; Murray A Mittleman; Mary B Rice
Journal:  Environ Epidemiol       Date:  2021-03-18

7.  Computational repurposing of therapeutic small molecules from cancer to pulmonary hypertension.

Authors:  Vinny Negi; Jimin Yang; Gil Speyer; Andres Pulgarin; Adam Handen; Jingsi Zhao; Yi Yin Tai; Ying Tang; Miranda K Culley; Qiujun Yu; Patricia Forsythe; Anastasia Gorelova; Annie M Watson; Yassmin Al Aaraj; Taijyu Satoh; Maryam Sharifi-Sanjani; Arun Rajaratnam; John Sembrat; Steeve Provencher; Xianglin Yin; Sara O Vargas; Mauricio Rojas; Sébastien Bonnet; Stephanie Torrino; Bridget K Wagner; Stuart L Schreiber; Mingji Dai; Thomas Bertero; Imad Al Ghouleh; Seungchan Kim; Stephen Y Chan
Journal:  Sci Adv       Date:  2021-10-20       Impact factor: 14.136

8.  Ambient Particulate Matter Induces Vascular Smooth Muscle Cell Phenotypic Changes via NOX1/ROS/NF-κB Dependent and Independent Pathways: Protective Effects of Polyphenols.

Authors:  Chia-Chi Ho; Yu-Cheng Chen; Ming-Hsien Tsai; Hui-Ti Tsai; Chen-Yi Weng; Shaw-Fang Yet; Pinpin Lin
Journal:  Antioxidants (Basel)       Date:  2021-05-14

9.  Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?

Authors:  Eleni Sofianopoulou; Colin Church; Gerry Coghlan; Luke Howard; Martin Johnson; David G Kiely; Allan Lawrie; James Lordan; Martin R Wilkins; Stephen J Wort; Nicholas W Morrell; Mark R Toshner
Journal:  Eur Respir J       Date:  2020-08-13       Impact factor: 16.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.